Vote For Cures
Nearly 50% of brand medicine spending goes to the supply chain and others
Let's Talk About Cost
New Resource Outlines Implications of Speaker Pelosi's Drug Pricing Plan
PhRMA Member Companies Raise Concerns With Impact Of Proposed International Pricing Index Model
The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.
latest from the
decline in hiv/aids death rates
Since the 1990s
The average cost to develop one new medicine.
Priority FDA review time thanks to PDUFA
Currently in development around the world.